The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma
Open Access
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (12) , 2210-2214
- https://doi.org/10.1038/bjc.1998.368
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Serum levels of slCAM-1 and 5-S-cysteinyldopa as markers of melanoma progressionMelanoma Research, 1997
- The S100 family of EF-hand calcium-binding proteins: functions and pathologyTrends in Biochemical Sciences, 1996
- Prognostic value of serum analyses of S-100β protein in malignant melanomaMelanoma Research, 1996
- Clinical significance of serum S100 in metastatic malignant melanomaEuropean Journal Of Cancer, 1995
- Measurement of S-100 Protein in Human Blood and Cerebrospinal Fluid: Analytical Method and Preliminary Clinical Resultscclm, 1995
- S-100 protein remains a practical marker for melanocytic and other tumoursMelanoma Research, 1993
- Neuron specific enolase (NSE) in serum of patients with malignant melanomaCancer Letters, 1990
- Detection of S-100 protein as an aid to the identification of melanocytic tumorsInternational Journal of Cancer, 1982
- S100 protein is present in cultured human malignant melanomasNature, 1980
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970